Therefore, TLE1 may have tumor suppressive roles in T-ALL development, consistent with the observation that low TLE1 expression is associated with poorer survival in T-ALL patients (Brassesco et al., 2018; Aref et al., 2021). Here, TLE1 is linked to acute lymphoblastic leukemia.